Dong M - Search Results

1

Aberrant expression of enhancer of zeste homologue 2, correlated with HIF-1α, refines relapse risk and predicts poor outcome for breast cancer.

Dong M, Fan XJ, Chen ZH, Wang TT, Li X, Chen J, Lin Q, Wen JY, Ma XK, Wei L, Ruan DY, Lin ZX, Liu Q, Wu XY, Wan XB. Dong M, et al. Oncol Rep. 2014 Sep;32(3):1101-7. doi: 10.3892/or.2014.3322. Epub 2014 Jul 10. Oncol Rep. 2014. PMID: 25017254

2

[Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].

Lin Q, Dong M, Wang QM, Wen JY, Wu XY. Lin Q, et al. Among authors: dong m. Ai Zheng. 2006 Oct;25(10):1261-5. Ai Zheng. 2006. PMID: 17059772 Chinese.

3

[Serum levels of macrophage migration inhibitory factor and interleukin-8 in hepatocellular carcinoma patients: their correlations with tumor progression and prognosis].

Lin Q, Huang MS, Hu B, Dong M, Wen JY, Wu XY. Lin Q, et al. Among authors: dong m. Zhonghua Gan Zang Bing Za Zhi. 2007 Jun;15(6):463-4. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17594817 Chinese. No abstract available.

4

[Efficiency of prevention and treatment of veno-occlusive disease of the liver after allogeneic stem cell transplantation].

Dong M, Lin Q, Wu XY. Dong M, et al. Ai Zheng. 2008 Jun;27(6):646-9. Ai Zheng. 2008. PMID: 18570742 Free article. Chinese.

5

Human tissue-specific microenvironment: an essential requirement for mouse models of breast cancer.

Xia TS, Wang J, Yin H, Ding Q, Zhang YF, Yang HW, Liu XA, Dong M, Du Q, Ling LJ, Zha XM, Fu W, Wang S. Xia TS, et al. Among authors: dong m. Oncol Rep. 2010 Jul;24(1):203-11. doi: 10.3892/or_00000847. Oncol Rep. 2010. PMID: 20514463

6

Prognostic analysis of acute exacerbations of hepatitis-B after chemotherapy in combination with rituximab in 19 patients with lymphoma.

Li X, Lin Q, Dong M, Wen JY, Wei L, Ma XK, Chen ZH, Wu XY. Li X, et al. Among authors: dong m. Leuk Lymphoma. 2010 Sep;51(9):1678-85. doi: 10.3109/10428194.2010.499486. Leuk Lymphoma. 2010. PMID: 20807095

7

The treatment of severe hepatitis B virus reactivation after chemotherapy.

Li X, Xing YF, Lin Q, Dong M, Wan XB, Wu XY. Li X, et al. Among authors: dong m. Nat Rev Clin Oncol. 2012 May 1;9(6):350; author reply 350. doi: 10.1038/nrclinonc.2012.1-c1. Nat Rev Clin Oncol. 2012. PMID: 22547218 No abstract available.

8

Beclin 1 activation enhances chemosensitivity and predicts a favorable outcome for primary duodenal adenocarcinoma.

Wu XY, Chen J, Cao QH, Dong M, Lin Q, Fan XJ, Xia Q, Chen ZH, Liu Q, Wan XB. Wu XY, et al. Among authors: dong m. Tumour Biol. 2013 Apr;34(2):713-22. doi: 10.1007/s13277-012-0599-5. Epub 2012 Dec 7. Tumour Biol. 2013. PMID: 23225331

9

An optimized antiviral modification strategy for prevention of hepatitis B reactivation in patients undergoing prophylactic lamivudine and chemotherapy: a pilot study.

Wu XY, Li X, Chen ZH, Wen JY, Lin Q, Xing YF, Dong M, Wei L, Wang TT, Chen J, Lin ZX, Wan XB, Ruan DY, Ma XK. Wu XY, et al. Among authors: dong m. Tumour Biol. 2013 Apr;34(2):909-18. doi: 10.1007/s13277-012-0626-6. Epub 2012 Dec 27. Tumour Biol. 2013. PMID: 23269606

10

Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.

Li X, Dong M, Lin Q, Chen ZH, Ma XK, Xing YF, Wan XB, Wen JY, Wei L, Chen J, Wu XY. Li X, et al. Among authors: dong m. Asia Pac J Clin Oncol. 2013 Mar;9(1):86-92. doi: 10.1111/ajco.12050. Epub 2012 Dec 27. Asia Pac J Clin Oncol. 2013. PMID: 23279888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,494 results

Search Page

Filters